TMEM45A Activators
TMEM45A Activators, a distinct chemical class, are molecules specifically selected for their ability to enhance the functional activity of TMEM45A, a transmembrane protein encoded by the TMEM45A gene. These activators exert their effects by modulating the cellular pathways and processes that TMEM45A is intricately involved in, thereby leading to an upregulation of its activity. The activation process, while complex and multifaceted, does not entail an increase in the protein's expression levels but rather centers on the protein's functional capacity. This is achieved through a variety of mechanisms, each relating to the unique properties of the activators and their interactions with cellular signaling cascades. For instance, certain activators may interact with membrane lipids surrounding TMEM45A, altering the membrane dynamics and thus indirectly enhancing the protein's activity. Others might engage with regulatory proteins or secondary messengers that, in turn, influence the functional state of TMEM45A.
The biochemical activation mechanisms of TMEM45A Activators are as diverse as the compounds themselves. Some activators may bind to allosteric sites on enzymes within the same signaling pathways as TMEM45A, leading to conformational changes that propagate through the pathway and ultimately result in the activation of TMEM45A. Others could act by modifying the oxidation-reduction state in the cellular environment, thereby influencing TMEM45A's activity indirectly through redox-sensitive switches. These activators ensure that TMEM45A's role in various cellular processes is carried out more efficiently, which is a testament to the specificity with which they engage the relevant signaling pathways. The overarching theme in the mode of action of TMEM45A Activators is the enhancement of the protein's function without altering its innate structure or expression levels, an attribute that underscores the precision of these molecular interventions in cellular biochemistry.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, which increases cAMP levels in cells. Elevated cAMP enhances the activity of protein kinase A (PKA), which can phosphorylate and thus increase the activity of TMEM45A by promoting its stabilization or enhancing its function in cellular processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can lead to phosphorylation of downstream proteins. The activation of PKC may enhance the activity of TMEM45A by promoting its insertion into cellular membranes where it may exert its function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, triggering calcium-dependent signaling pathways. Elevated calcium levels can indirectly enhance TMEM45A activity by modifying the protein's conformation or its interaction with other cellular components. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a tyrosine kinase inhibitor that can modulate signaling pathways by inhibiting phosphorylation events. This inhibition may result in the enhancement of TMEM45A activity by reducing competitive phosphorylation or by stabilizing the protein. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the PI3K/AKT signaling pathway. By inhibiting PI3K, LY294002 may enhance TMEM45A activity indirectly by affecting the membrane trafficking or localization of the protein. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that raises intracellular calcium levels, which could enhance the activity of TMEM45A by influencing calcium-dependent proteases that may process or activate the protein. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to its receptors, initiating a signaling cascade that can lead to cytoskeletal rearrangements. This signaling may enhance TMEM45A activity by facilitating its interaction with the cellular framework, affecting its functional state. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a non-selective protein kinase inhibitor that, by inhibiting certain kinases, may enhance TMEM45A activity by reducing the phosphorylation of competing pathways, thereby indirectly stabilizing TMEM45A function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may enhance TMEM45A activity by altering stress response pathways. This modification could lead to an indirect increase in TMEM45A activity by shifting cellular responses to favor TMEM45A pathway utilization. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that may enhance TMEM45A activity by affecting the protein's distribution within the cell or influencing its interaction with other signaling molecules. | ||||||